DrugsControl Media Services

News Detail

NPPA modifies guidelines for change in manufacturer to allow existing market entity to produce in its own plant (16-08-2023)

New Delhi, 16 Aug 2023: The National Pharmaceutical Pricing Authority (NPPA) has modified the parameters in its guidelines for allowing change of manufacturers after retail price of formulations are approved, allowing the existing marketing entity to produce the medicine in its o......
View Details

Source : Pharmabiz
National Pharmaceutical Pricing Authority NPPA parameters retail price Form V DPCO 2013 Central or State Licensing Authority Novartis India Voveran Nitin Life Sciences ESG Policy Sovereign Pharma Torrent Pharma chlorthalidone telmisartan Rozucor Gold Synokem Pharma

Related News